never had an issue with CEO salary that was vestedin except this company REALLY stands out like a sore thumb.
all the cheerleaders are hoping, yes please wait, yes MC will go up, blah blah, the SP does not lie after 4 years, any value by strategic would have been picked up long ago the low skin in the game, etc, etc TIME FOR A CHANGE. this management should be quietly set aside to save the $1.8m salary and other 6 figure salaries from other executives (this is not large pharma) and use the share holder money into the clinical/regulatory trials streams for accelerating FDA approved asap when SP will finally increase exponentially at this inflexion point and meanwhile whynot hire a part time CEO med tech guy/lady on a lower salary and give them plenty of share options to manage this process until we get here, cannot see that harming SP
- Forums
- ASX - By Stock
- Watchthisspace tweet
never had an issue with CEO salary that was vestedin except this...
-
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$13.14 |
Change
0.140(1.08%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$13.20 | $13.50 | $13.14 | $559.5K | 42.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1180 | $13.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.35 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 13.000 |
1 | 1000 | 12.950 |
2 | 67 | 12.900 |
1 | 1000 | 12.800 |
1 | 37 | 12.000 |
Price($) | Vol. | No. |
---|---|---|
13.350 | 500 | 1 |
13.500 | 2000 | 1 |
13.510 | 46 | 1 |
13.900 | 300 | 1 |
14.440 | 25 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |